Being able to predict that a patient will adversely react to a drug that's meant to be treating them is a key aim of personalised medicine, and could help to improve the patient's overall treatment.
Jan 22, 2015
0
4
In her 28-year career, Dr. Deborah Axelrod, a New York physician, says she's had just one patient whose advanced breast cancer inexplicably vanished.
Sep 22, 2014
3
0
Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life ...
Jun 10, 2013
0
0
The fatigue experienced by patients undergoing cancer treatments has long been recognized by health care providers, although its causes and ways to manage it are still largely unknown.
Mar 8, 2013
1
0
